Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): Overall findings from eight countries

Current Medical Research and Opinion

Volumn 26, Issue 2, 2010, Pages 445-454

  Hermans, Michel P ^a   Castro Cabezas, Manuel ^b   Strandberg, Timo ^c   Ferrires, Jean ^d   Feely, John ^e   Elisaf, Moses ^f   Michel, Georges ^g   Sansoy, Vedat ^h  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d CHU RANGUEIL   (France)

^e ST JAMES S HOSPITAL   (Ireland)

^f UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^g CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^h ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hypercholesterolaemia; LDL C; Lipid lowering drugs; Statins; Undertreatment

Indexed keywords

ATORVASTATIN; BILE ACID SEQUESTRANT; EZETIMIBE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; BODY MASS; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED STUDY; DATA COLLECTION METHOD; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG USE; EUROPE; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOTHERAPY; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; GUIDELINE ADHERENCE; HEALTH PLANNING GUIDELINES; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; TREATMENT FAILURE; YOUNG ADULT;

EID: 74549195050     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903500565     Document Type: Article

References (23)

1. Sans S, Kesteloot H, Kromhout D, on behalf of the Task Force. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997;18:1231-1248 (Pubitemid 27332143)
2. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 1994;308:367-372
3. Law MR, Wald NJ. An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur J Clin Nutr 1994;48:305-325
4. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003;326:1423
5. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24:1601-1610
6. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and, treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and, treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 2002; 106:3143-3421
7. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2007; 28:2375-2414
8. Grundy SM, Cleeman JI, Merz CN, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110:227-239
9. Iglseder B, Moroder T, Staffen W, et al. High prevalence and undertreatment of hypercholesterolaemia in participants in a public stroke prevention programme in Austria. Clin Drug Investig 2005;25:709-717
10. Diamantopoulos EJ, Athyros VG, Yfanti GK, et al., OLYMPIC Study Group. The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study. Angiology 2005;56:731-741
11. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Eur Heart J 2001; 22:554-572
12. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001;357:995-1001
13. Kindermann M, Adam O, Werner N, et al. Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007-EUROASPIRE III. Clin Res Cardiol 2007;96:767-786
14. Malik S, Lopez V, Chen R, et al. Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Res Clin Pract 2007;77:126-133
15. Klingman D, Williams SA, Benner JS, et al. Gauging the treatment gap in dyslipidemia: findings from the 1999-2000 National Health and Nutrition Examination Survey. Am Heart J 2005;150:595-601
16. Grundy SM, Brewer Jr HB, Cleeman JI, et al. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438
17. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373:929-940
18. Penning-van Beest FJ, Termorshuizen F, Goettsch WG, et al. Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J 2007;28:154-159
19. Daskalopoulou SS, Delaney JA, Filion KB, et al. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J 2008;29:2083-2091
20. Simons LA, Levis G, Simons J. Apparent discontinuation rates inpatients prescribed lipid-lowering drugs. Med J Aust 1996;164:208-211
21. Hermans MP, Van Mieghem W, Vandenhoven G, et al. Centralized Pan-European survey on the undertreatment of hypercholesterolaemia (CEPHEUS). Acta Cardiol 2009;64:177-185
22. Ferriè res J, Gousse ET, Fabry C, et al., on behalf of the French CEPHEUS Investigators. Assessment of lipid-lowering treatment in France-The CEPHEUS study. Arch Cardiovasc Dis 2008;101:557-563
23. Michel G, Muller P. Pan-European survey on the undertreatment of hyperch-olesterolemia in hypolipidemias (Luxembourg). Bull Soc Sci Med Grand Duche Luxemb 2008;4:509-516